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ABSTRACT 
A reaction involving iron as an intermediary electron carrier for the 
coupling of electron transfer from an endogenous substrate to ferroxidase-I 
has been proposed. 
The enzymic nature of the reaction has been established and studies 
with iron chelating agents have demonstrated the involvement of Fe(III). 
The kinetic parameters of ferroxidase-11 with Fe(lll) were found to be 
quite similar to those previously established for Fe(Il). The participa-
tion by the copper associated with ferroxidase-11 was ascertained by use 
of the copper chelating agent, diethyl-dithio-carbamate. 
A variety of substances normally found in blood were surveyed as pos-
sible candidates for the endogenous substrate but none were oxidized by 
ferroxidase-11 in a coupled reaction with Fe(lll). Comp)ete loss of the 
Fe(lll)-initiated oxidase activity was observed when ferroxidase-11 was 
treated with phospholipase C and passed over a column of Agarose A-5m. 
This procedure removes the bound lipid from ferroxidase-lI and the loss 
of activity observed suggested that the endogenous substrate was a lipid 
or was dissolved in the lipid matrix of the enzyme. Attempts to reconsti-
tute this activi~ with lipid extracts of ferroxidase-11 were unsuccessful. 
The endogenous substrate responsible for the Fe(Ill)-initiated reaction 
was not definitely identified; however, significant progress towards its 
characterization was made. 
LITERATURE REVIEl~ 
The element copper is fundamental to the life processes of both 
plants and animals. Copper has long been a familiar element but its 
presence in biological systems has been known for only 150 years. One 
of the reasons its presence has gone undetected until recent times is 
that copper deficiency is rare in plants and has never been observed in 
animals. This is due to the natural abundance of copper in the diet. 
An excess of copper could be toxic but the protective mechanisms in the 
body restrict the absorption of copper and other metals. 
Copper's importance arises from the fact that it is a required con-
stituent of numerous essential proteins and enzymes. Although the amount 
of copper required by organisms is quite small, it is indispensable to 
the life processes. The adult human body contains only about 100 m~lli­
grams of copper, a small amount, but one which is vital to our existence. 
In living systems it is very difficult to determine precise forms 
and locations of copper. This is true because copper is seldom found in 
any biological compound less complicated than a protein. Nearly all of 
the 100 milligrams of copper in the human body is incorporated into pro-
teins. A few of the copper proteins are given in Table I. 
There are primarily three properties which make copper so ideally 
suited for metabolic processes(l): 
1. copper ions react with amino acids or proteins more 
strongly than other metal ions do 
2. copper is an exceptionally effective catalytic agent 
3. copper's ionization states have flexible properties 
that qualify it uniquely for metabolic functions 
The element copper is a member of the first transition series. Sev-
eral of the elements of this series share these three important properties 
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TABLE I 
IMPORTANT COPPER PROTEINS AND ENZYMES 
Name 
Cytochrome 
oxidase 
Hemocyanin 
Ceruloplasmin 
Amine oxidase 
Tyrosinase 
Dopamine-s-
hydroxylase 
Ga lactose 
oxidase 
Erythrocuprein 
Ascorbic acid 
oxidase 
Plastocyanin 
Where Found 
Most plants and 
animals 
Mollusk and arthro-
pod plasma 
Plasma of most 
animals 
Most animals, etc. 
Animal skin, 
melanoma, insects, 
pl ante::. 
Adrenals 
Molds 
Red blood cells of 
most animals 
Many plants 
Algae, green leaves 
and other plants 
mo!.wt 
10 gm 
70 
450-
6, 680 
l 51 
225 
35 
100 
290 
75 
34 
150 
21 
Biochemical 
Function 
Termi na 1 oxi dase 
Oxygen carrier 
Fe(III)-transferrin 
formation, Copper 
transport 
Elastin, collagen 
formation 
Tyrosine oxidation, 
skin pigment 
(melanin) formation 
Epinephrine 
biosynthesis 
Galactose oxidation 
Superoxide dismutase 
Terminal oxidase 
Photosynthesis 
and also serve as biological trace elements. Although they do serve as 
trace elements, each is very specific in its function. 
Research concerning the biological role of copper has greatly ex-
panded since the recognition of its involvement in a number of important 
physiological processes(2,3,4). The best known of these is copper's in-
volvement in hemoglobin formation(5,6,7). 
The principal metabolic disturbances arising as a result of copper 
deficiency are as follows(8): 
1. reduction in the absorption and utilization of iron 
leading to hypochromic and microcytic anemia and a 
deficiency of heme enzymes including cytochrome oxidase 
2. a defect in phospholipid biosynthesis resulting in 
demyelination and 11 swayback 11 disease in lambs 
3. impairment of osteoblastic activity leading in some an-
imals to skeletal changes similar to those reported in 
scurvy 
4. abnormalities in keratin and pigment formation resulting 
in wool defects in lambs and achromotrichia in rats 
In 1928, Hart et al(5) were the first to report anemia in copper-
deficient animals. Since the early 1950's, Cartwright, Wintrobe, and 
their associates at the University of Utah School of Medicine have done 
extensive research on this defect in iron metabolism. Their studies led 
them to propose a role for copper in the biosynthesis of hemoglobin(7,9). 
They theorized that copper could act at any of the three main lines of 
hemoglobin biosynthesis: the biosynthesis of protoporphyrin of heme, the 
utilization of iron, or the biosynthesis of globin. Earlier work by Lee 
et al(lO) showed that as anemia developed there was an increase in the 
activity of heme biosynthetic enzymes. Thus, it did not appear that cop-
per acted at this point of hemoglobin biosynthesis. Since there was no 
evidence for impairment of the biosynthesis of globin, they concluded that 
copper was important in the proper utilization of iron(lO). In 1966) Osaki 
et al reported on the possible significance of the ferroxidase activity 
of a copper protein, ceruloplasmin. They proposed that its catalytic 
activity involved promoting the rate of iron saturation of transferrin 
and iron utilization in the plasma(ll). 
Ceruloplasmin was first isolated and characterized in 1947 by the 
Swedish biochemists Holmberg and Laurell(l2). They found the protein to 
have a molecular weight of approximately 151 ,000 and a copper content of 
eight atoms per molecule. Ceruloplasmin is found in the plasma of most 
vertebrates and normally accounts for over 98% of the serum copper. 
Since ceruloplasmin had greater than 98% of the serum copper bound 
to it, many believed that ceruloplasmin was directly involved in the trans-
fer of copper. To test this hypothesis, a radioactive copper salt was 
injected into a human body. The copper first appeared in combination with 
the serum albumin in the bloodstream. From there it was rapidly absorbed 
by the liver and finally reappeared in the serum in the fonn of cerulo-
plasmin(l). Thus, ceruloplasmin could be a convenient storage form of 
copper ion, thereby preventing its interaction with other proteins. 
In later studies of ceruloplasmin, Holmberg and Laurell found oxidase 
activity in vitro towards many substrates. They observed max·imum substrate 
activity with p-phenylenediamine(PPD). They also found the activity of 
ceruloplasmin to be ma.rkedly affected by anions(l4). Walaas and coworkers 
(15,16) have reported that catecholamines serve as substrates for cerulo-
plasmin although their reaction rates are slower than those observed with 
PPD. In 1958 Broman reported inhibition of crude ceruloplasmin by dicar-
boxyl ic acids and ethylenediaminetetraacetic acid(l7). In 1960, Curzon 
reported the results of his studies on the effects of some anions, cations 
and chelating agents on the oxidase activity of purified ceruloplasmin. 
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He observed that low concentrations of metal ions, in particular Fe(II), 
increased the activity of ceruloplasmin. In similar studies Curzon ob-
served inhibition of activity at higher metal ion concentrations(l8). In 
1960, Curzon and O'Reilly(l9) noted the catalytic oxidation of Fe(II) by 
ceruloplasmin. Their data indicated a coupled iron-ceruloplasmin oxida-
tion system to be involved. 
S. Osaki(20) studied the kinetics of the catalysis of Fe(II) oxida-
tion by crystalline human ferroxidase. At the pH optimum of 6.5 Osaki 
obtained two K values with respect to Fe(II). Competition between the m 
two substrates PPD and Fe(II) was also observed(20). 
Huber and Frieden(21) found that the ceruloplasmin catalyzed oxi-
dation of Fe(II) and aromatic diamines exhibited nonlinear kinetics in 
Eadie-Hofstee plots. They accounted for the kinetics of Fe(II) oxidation 
by a mechanism based on substrate activation. 
In a subsequent study, Huber and Frieden studied the inhibition of 
ferroxidase by trivalent and other metal ions. They observed inhibition 
with all trivalent ions tested but strongest inhibition was from those 
ions which had an ionic radius of 0.81A or less(22). 
As reported earlier, Osaki et al(ll) were interested in the role of 
ceruloplasmin in hemoglobin biosynthesis. In 1966, they reinvestigated 
the problem of serum Fe( II) oxidation under conditions approaching the 
state in vivo. They estimated the nonenzymic oxidation of Fe(II) to be 
insufficient to account for a rate of Fe(III)-transferrin formation nec-
essary to provide adequate iron supply for hemoglobin and other biosyn-
theses requiring Fe(II). These results suggested an appreciable catalytic 
activity was involved in Fe(II) oxidation in serum. From their work they 
proposed a biological role for ceruloplasmin in converting Fe(II) to Fe(III), 
I 
thereby promoting the rate of incorporation of Fe(III) into apotransferrin. 
This leads directly to the biosynthesis of hemoglobin and other iron-utiliz-
ing systems(23). The possible role of ceruloplasmin is illustrated below(ll): 
H20 xceruloplasminx2Fe(II) 
1/202 reduced 2Fe(III) 
ceruloplasmin ""\ ... r apotrans ferri n 
transferrin 
The ferroxidase activity of ceruloplasmin explains its broad capacity 
to catalyze the oxidation of a variety of reducing agents, all of which 
react with ferric ion. Thus it was proposed(ll) that when describing the 
enzymic activity of ceruloplasmin, it be designated as a ferro-02 -oxido-
reductase or simply ferroxidase. Thus, the term ferroxidase is often used 
to describe ceruloplasmin's catalytic activity and its specific role in 
iron mobilization. 
Johnson, Osaki and Frieden reported a very strong positive linear 
correlation between PPD oxidase activity and ferroxidase activity(24). 
With the exception of Wilson's disease sera, this correlation was observed 
in normal as well as in pathological sera. 
There is now considerable evidence supporting the proposal that 
ceruloplasmin is the key link between iron and copper metabolism. The 
best evidence comes from Ragan et al(25) at the University of Utah School 
of Medicine. They observed a rapid rise in plasma iron upon injection of 
ceruloplasmin in in vivo studies with copper-deficient pigs. 
Subsequent studies by Cartwright, Lee and coworkers have demonstrated 
that a rise in serum ferroxidase activity precedes a rise in serum iron 
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following copper injection. This rise in plasma iron concentration was 
followed by a gradual rise in the hemoglobin concentration of the blood 
stream(26). These experiments at the University of Utah indicated that 
the defect in the release of iron in the copper-deficient animal is quickly 
reversed by intravenous ceruloplasmin(l3). Osaki et al confirmed these 
results in their studies of iron mobilization from perfused mammalian 
livers(27,28). 
Although the evidence for the role of ceruloplasmin in iron mobili-
zation was quite strong(ll ,13,25,26,27,28), there was no explanation·for 
the normal iron mobilization found in Wilson's disease (Hepatolenticular 
Degeneration). 
In Wilson's disease, the serum is largely depleted of ceruloplasmin 
and copper diffuses into the tissues. The copper may then accumulate to 
high levels, especially in the liver and brain. If ceruloplasmin were the 
only ferroxidase in the sera, the Fe(II) oxidase activity would be expected 
to be reduced and a defect in iron metabolism should be observed. Johnson 
et al observed reduced PPD oxidase activity but there was still an appreciable 
Fe(II) oxidase activity(24). Thus, despite the reduction in ceruloplasmin, 
sufficient ferroxidase activity remained to prevent anemia(29). This find-
indicated the possibility of the presence of a modified ferroxidase or an 
additional unknown catalyst(29). 
In 1970, Topham and Frieden announced the identification and purifi-
cation of a second serum ferroxidase which they designated ferroxidase-II. 
They isolated this non-ceruloplasmin ferroxidase protein from normal as 
well as Wilson's disease sera(30). 
Some of the properties distinguishing ferroxidase-II from ceruloplasmin 
are given in Table II(30)-_ Three of the primary differences are that 
TABLE II 
PROPERTIES DISTINGUISHING FERROXIDASE-II FROM CERULOPLASMIN 
PROPERTY 
Inhibition with lmM 
Azide 
Apparent Km values for 
Fe(II) 
Specific activity 
(A4GO per lOmin per 
mg of protein) 
p-Phenylenediamine oxidase 
activity 
Elution after 
chromatographya 
Color of purified 
preparation 
Molecular Weight 
·Copper content(milli-
micromoles of copper 
per mg of protein) 
Immunoelectrophoretic 
migration from origin 
Effect of dialysisb 
CERULOPLASMIN 
> 98% 
2 
30 
Yes 
.2 to .3M 
NaCl re-
quired 
Blue 
151,000 
44 
Large 
rv 35% remaining 
activity 
FERROXIDASE-II 
None 
1 
4.9 
None 
No NaCl required 
Yellow 
> 800,000 
12 
Small 
100% activity 
aAdsorption on DEAE-Sephadex; eluted with .OSM Acetate buffer, 
pH 5.5, with or without .2 to .3M NaCl 
boialysis for 2 days at 4°C against .05M Acetate buffer, pH 5.5 
10 
ferroxidase-II: 
l. is yellow rather than blue as ceruloplasmin 
2. is not inhibited by azide 
3. exhibits no PPD oxidase activity 
Topham observed that oxygen consumption with ferroxidase-II occurred 
simultaneously with iron oxidation. 
Topham and Frieden found that although ferroxidase-II was decreased 
in Wilson's disease serum it was reduced to a lesser extent than ferroxi-
dase-I. They observed the total ferroxidase activity of Wilson's disease 
serum to be approximately 5 to 10% of that of normal serum(30). Osaki 
et al(28) had previously reported that only about 10% of the total fer-
roxidase activity of normal serum was necessary for maximum iron mobili-
zation response from the liver. Thus, the total ferroxidase activity of 
Wilson's disease serum accoLlnts for the maintenance of near normal iron 
metabolism(30). 
Gel filtration data and disc gel electrophoresis indicated that fer-
roxidase-II had a molecular weight greater than 800,000. Immunoelectro-
phoretic mobility, the oil red-staining property, and the large molecular 
weight suggested that it might be a serum lipoprotein(30). 
Sung and Topham(31,32) have recently reported the identification and 
quantitative analyses of the lipid components bound to ferroxidase-II. 
They found ferroxidase-II to contain lipids both in the form of cholesterol 
and phospholipid. Thin-layer chromatographic analyses were carried out 
to determine which individual phospholipids were bound to ferroxidase-II. 
Their findings indicated that phosphatidyl choline accounted for most of 
the bound phospholipid with small amounts of sphingomyelin and lysophos-
phatidyl choline accounting for most of the remaining phospholipid(31 ,32,33). 
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They also found that intact phospholipids appear essential for the enzymic 
activity of ferroxidase-II to be maintained. 
Topham et al(34,35) have reported a detailed study of the kinetics 
of Fe(II) oxidation by ferroxidase-II. Their findings are presented in 
Table III. Their results suggest that ferroxidase-II would be capable of 
functioning as an alternative for ferroxidase-I in human sera and as the 
major ferroxidase in the sera of species having low ferroxidase-I levels. 
TABLE III 
COMPARISON OF THE KINETIC PARAMETERS OF 
FERROXIDASE-I AND FERROXIDASE-II 
PROPERTY FERROXIDASE-I 
pH optimum 6.5 
Km ( s) for Fe(II) {µM) 0.6, 50 
K for 02 ( µM) 9.0 m 
Molar activity (µM Fe 550 
(III)/min)/{µM enzyme) 
Activity per Cu atom 
{µM Fe(III)/min)/(Cu 
69 
atom) 
12 
FERROXIDASE-II 
7.2 
14 
4. 1 
525a 
53 
acalculated assuming a molecular weight of 8 x 10 5 which was 
estimated from gel filtration and disc-gel polyacrylamide 
electrophoresis(32). 
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INTRODUCTION 
Huber and Frieden(22) previously reported that certain metal ions 
markedly influence the ferroxidase reaction catalyzed by ferroxidase-I. 
Substrate activation was observed with iron, whereas inhibition was 
observed with certain trivalent and other metal ions. These studies 
provided considerable insight into the molecular mechanism of the fer-
roxidase reaction catalyzed by ferroxidase-I. 
This thesis proposed to undertake similar experiments with ferroxidase-
II in the hopes of 1) further differentiating ferroxidase-II from fer-
roxidase-I and 2) providing information concerning the molecular mechanism 
of the ferroxidase reaction catalyzed by ferroxidase-II. 
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EXPERIMENTAL METHODS 
Isolation and Purification of Ferroxidase-II from.Human Plasma 
Pure ferroxidase-II was prepared from the Cohn IV-1 fraction of 
human plasma. The method was an adaptation of the procedure used 
previously by Topham and Frieden (30). This plasma fraction contains 
ceruloplasmin (ferroxidase-1) and ferroxidase-II as well as other con-
taminating proteins but contains only 5% of the total protein of blood 
plasma. Thus, Cohn IV-1 is an excellent starting material for the pur-
ification of ferroxidase-II. Five grams of lyophilized Cohn IV-1 
{obtained from the E. R. Squibb and Sons, Inc., New York, New York) was 
extracted with 100 ml of 0.05 M acetate buffer, pH 5.5, overnight at 4° 
with gentie continuous stirring. In order to remove any undissolved 
material, the resulting extract was centrifuged at 25,000 x gravity for 
30 minutes at 4°. The supernatant was then decanted through a thin 
layer of fine glass wool to remove the floating lipid layer. 
At pH 5.5 ferroxidase-I and ferroxidase-II differ greatly in charge. 
At this pH, ceruloplasmin is highly negatively charged; however, fer-
roxidase-II bears little charge. Thus, these two proteins may be completely 
separated by chromatography on an anion exchange resin, DEAE-Sephadex A~50. 
The entire extract of Cohn IV-1 was chromatographed on a DEAE-Sephadex A-50 
column (4 cm x 10 cm). The column was washed with 0.05 M acetate buffer, 
pH 5.5. Ferroxidase-II was eluted immediately following the void volume 
with 0.05 M acetate buffer, pH 5.5. Ferroxidase-II came off the column as 
a turbid yellow solution. Ferroxidase-I remained as a small blue-green 
band at the top of the column. The ferroxidase-II containing solution 
was then concentrated to 30 ml by ultrafiltration in an Amicon ultrafiltration 
cell equipped with a Diafl6 PM-30 membrane. 
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For further purification, the concentrated ferroxidase-II solution 
was applied to an Agarose A-50 M column (4 cm x 55 cm). Agarose A-50 M 
is a molecular sieving gel for proteins of molecular weight 10 x 104 t · 
50 x 106. Two bands having ferroxidase activity were eluted with 0.05 M 
acetate buffer, pH 5.5. The first band was yellowish and very turbid and 
contained 10 - 12% of the ferroxidase-II activity. Approximately 90% of 
the ferroxidase-II activity was eluted as a second band which was clear 
yellow in color. This band was collected, concentrated to approximately 
30 ml and passed through another Agarose A-50 M column (4 cm x 55 cm). 
A clear yellow protein band possessing ferroxidase-II activity was eluted 
from this column. This band was then concentrated to a final protein 
concentration of approximately 20 mg/ml. 
Quantitative Determination of Protein 
Protein concentrations were determined by the method of O.H. Lowry (36). 
This is a spectrophotometric assay combining the use of the biuret and 
phenol reagents. There are basically two steps which lead to the final 
color with the protein. In the biuret reaction, the protein reacts with 
a strongly alkaline, but dilute solution of copper sulfate producing a 
violet color. The second step involves the reduction of the phosphomolyb-
dic-phosphotungstic reagent (Phenol Reagent) by the copper-treated protein. 
The reduction of this reagent is due to the tyrosine and tryptophane present 
in the protein. This method has the advantages of being rapid, sensitive 
and specific for protein. The limit of detection is 5 pg/ml with a sen-
sitivity 100 times that of the biuret reaction and 10-20 times the value 
obtained by measurement of the ultraviolet absorption at 280 nm. 
In the analysis, duplicate one ml samples of a bovine serum albumin 
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solution (0.2 mg/ml} and 1 ml of a distilled water blank were placed 
into colorimetric tubes. The solution of unknown protein concentration 
was diluted 1:10 (v/v} and l ml was placed into a colorimetric tube. 
Five ml of Lowry B solution (2% Na2 C0 3 ; 0.1 M NaOH; 0.01% CuS04; 0.02% 
sodium tartrate} were then added to the tubes which were mixed and al-
lowed to stand ten minutes. After ten minutes, 0.5 ml of phenol reagent 
(Phipps and Bird, Richmond, Virgin~a; diluted 1/1 with water) was added 
to each tube. Maximum color was developed in one hour, at which time, 
the absorbance of each tube at 600 nm was recorded. 
Method of Assay of Enzymic Activity 
Ferroxidase assays were carried out using the Gilson Model K-ICC-RP 
Oxygraph with a Clark-type polarographic oxygen electrode. The basis of 
the procedure is illustrated in the following equations: 
(1) 
(2) 
Fe2+ + E 
ox 
+ Fe3+ + E 
red 
The cell containing the electrode system was maintained at 30°C 
with a Haake FJ thermostatted bath. The instrument was standardized at 
30°C assuming the oxygen concentration of air saturated water to be 236 
micromolar (35}. 
The standard polarographic assay procedure for ferroxidase activity 
was conducted in the manner outlined below. The reaction mixture used 
for assays contained 7 parts by volume of 0.6 M acetate buffer, pH 6.0 
(final concentration 0.2 M), 6 parts by volume of a 4 x 10-4 M ferrous 
ammonium sulfate solution (final concentration 120 micromolar}, and 5 
parts by volume of distilled water. For each assay, 2 ml of the reaction 
mixture was pipetted into the reaction vessel and allowed to equilibrate. 
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Once a steady base line was established, 50 µl of the enzyme preparation 
was injected and the rate of oxygen consumption was recorded. The specific 
activity was recorded as micromoles of oxygen consumed per minute per mg 
protein. 
In order to study the enzymic activity with the ferric ion, it was 
necessary to make a slight modification of the above procedure. For these 
analyses, a reaction mixture containing 0.6 M acetate buffer, pH 6.0 
diluted 1:3 (v/v) was used. A series of standard iron (III) solutions 
were made and varying amounts of these were injected into the reaction 
vessel. As before, the specific activity was recorded as micromoles of 
oxygen consumed per minute per mg protein. 
Any variations from the standard procedure will be specifically 
enumerated in the legends to the figures or tables resulting from these 
special experiments. 
Treatment of Ferroxidase-II with Phospholipase C 
Phospholipase C treatments were performed according to the method of 
Topham and Gaylor (37) and Sung and Topham (32). Four ml of purified 
ferroxidase-II (18 mg/ml), 0.7 mg of phospholipase C (Type 1) and 0.145 ml 
of 0.4 M CaC1 2 were incubated for two hours at 30°. Controls containing 
purified ferroxidase-II·, CaC1 2 , but no phospholipase C were incubated under 
identical conditions. After incubation, the ferroxidase activities of the 
samples and of the controls were determined. 
Spectral Studies of Fe(III) Reduction by Ferroxidase-II 
Spectral studies of the enzyme catalyzed reaction were performed 
using a Perkin-Elmer Model 450 UV-Visible NIR spectrophotometer. The 
instrument was used in the double beam mode. 
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These experiments were designed to determine whether Fe(III) was 
being reduced in a coupled reaction with ferroxidase-II. The basic com-
ponents of the reference and sample cells were as follows: 
Reference cell: reaction mixture (0.2 M Acetate buffer, pH 6.0) 
containing 1 x 10-2 M a,a'-dipyridyl or 1 x 10-2 M 1 ,10-phenan-
throline, 1 x 10- 3M Fe(III), 100 µl of 0.05 M Acetate buffer, 
pH 5.5 
Sample cell: reaction mixture (0.2 M Acetate buffer, pH 6.0) con-
taining 1 x io-2 M a,a'-dipyridyl or 1 x io- 2 M 1,10-Phenanthro-
line, 1 x 10- 3 M Fe(III), 100 µl{0.91 mg) ferroxidase-II 
Control spectra were run to determine the absorbance of the various com-
ponents of the reference and sample cell. 
To determine the absorbance of ferroxidase-II, the reference cell 
contained the reaction mixture and 100 µl of 0.05 M Acetate buffer, pH 5.5. 
In the sample cell, 100 µl{0.91 mg) of ferroxidase-II was substituted for 
the Acetate buffer. 
The possible absorbance by Fe(III) and ferroxidase-II was examined 
by addition of l x 10- 3 M Fe(III) to the sample and reference cell used 
to determine the absorbance of ferroxidase-II. 
To look at the absorbance due to the chelating agents and the enzyme, 
the sample and reference cells included the following: 
Reference cell: reaction mixture (0.2 M Acetate buffer, pH 6.0) 
containing l x 10-2 M a,a'-Dipyridyl or 1 x 10-2 M 1,10-Phenan-
throline, 100 µl of 0.05 M Acetate buffer, pH 5.5 
Sample cell: reaction mixture (0.2 M Acetate buffer pH 6.0) con-
taining 1 x 10-2 M a,a'-Dipyridyl or 1 x 10-2 M l ,10-Phenanthro-
line, 100 µl{0.91 mg) ferroxidase-II 
Treatment of Ferroxidase-II with Diethyl-Dithio-Carbamate (OTC) 
In order to bind the copper associated with ferroxidase-II, the 
enzyme was treated with the copper chelating agent, OTC. A stock 
19 
solution of 10-2 M OTC was made in 0.05 M acetate buffer pH 5.5. This 
solution was added to the purified ferroxidase to yield a final OTC .con-
centration of 10- 3 M. After standing, the mixture was dialyzed against 
acetate buffer to remove excess chelating agent. 
Metal Inhibition Studies 
To remove trace amounts of contaminating metals, all glassware and 
containers were washed with concentrated HCl, then rinsed several times 
with glass-distilled water. 
Routinely, the reaction mixture (0.6 M acetate buffer diluted 1+3) 
was placed in the reaction cell and allowed to equilibrate. After equil-
ibration, 50 µl(l .04 mg). of ferroxidase-II and varying amounts of standard 
Fe(I II) so 1 uti ons were added and a 11 owed to incubate for two minutes. Next, 
Fe(II) was added (120 µM final concentration) and the reaction was allowed 
to proceed. Throughout this procedure, the activity was monitored as micro-
moles of oxygen consumed per minute. 
Extraction of Lipids from Ferroxidase-II 
The lipid components of ferroxidase-II were isolated and purified by 
the procedure of Folch et al (38). Routinely, lipids were extracted from 
10 ml of ferroxidase-II by stirring overnight with 200 ml of chloroform/ 
methanol (2:1, v/v). The extract was then washed with 50 ml of distilled 
water. This resulted in a two phase system with the chloroform (lower). 
phase containing the extracted lipids. The washing step was repeated until 
the chloroform layer appeared clear. If an emulsion formed during the 
washing procedure, solid NaCl was added as a dispersing agent. The 
chloroform layer was evaporated to 15 ml and an equal volume of 95% 
ethanol was added. This mixture \'-las evaporated to dryness in a tared 
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flask under a stream of nitrogen. The flask was then reweighed and the 
yield was determined. 
A stock solution of lipids was prepared by dissolving the extracted 
lipids in 10 ml of chloroform/methanol (2:1, v/v). For each experiment, 
a quantity of the stock so 1 ution was removed, evaporated to dryness and -
dissolved in the desired solvent. Controls with the solvent in the absence 
of the ~xtracted lipids were also run. 
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RESULTS 
Frequently, end product inhibition is a mechanism by which cells 
control the rate of certain metabolic reactions. Therefore, the logical 
starting point in the investigation of the effect of metal ions on fer-
roxidase-II seemed to be a study of the effect of Fe(III). Thus, Fe(III) 
was initially examined as a possible inhibitor of ferroxidase-II. 
Interaction of Ferroxidase-II with Fe(III) 
Unexpectedly, oxygen consumption was observed immediately following 
the injection of Fe(III) (Figure 1). This observation suggested that 
Fe( III) initiated an oxidase type reaction with ferroxidase'.""II. Since 
Fe(III) is the highest stable oxidation state of iron, the further ox-
idation of Fe(III) by ferroxidase-II would be extremely unlikely. Thus, 
it appeared that Fe(III) must be initiating the oxidation of some sub-
stance endogenous in the ferroxidase-II preparation. Additional studies 
were undertaken to ascertain why Fe(I II) i ni ti ated oxygen consumption with 
ferroxi dase-I I. 
Enzymic Nature of the Fe(III) Reaction 
If the Fe(III)-initiated reaction with ferroxidase-II is indeed an 
enzymic process, then saturation kinetics should be observed for the 
reaction and heat treatment should result in the loss of the Fe(III)-ini-
tiated activity. 
A plot (Figure 2) of the specific activity of the Fe(III}-initiated 
reaction versus the substrate concentration did exhibit saturation kinetics. 
Treatment of ferroxidase-II at 100° for 5 minutes resulted in the complete 
loss of the Fe(III)-initiated reaction. 
The determination of the basic kinetic parameters of the Fe(III)-
initiated reaction seemed to be the next logical step. 
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FIGURE 1 
Time Course of Oxygen Consumption with the Fe(III)-initiated R~~ction 
with Ferroxidase-II 
The reaction mixture contained 50 ~l (1.04 mg) of purified ferroxidase-
II and a final Fe(III) concentration of 1 x l0-3 M. 
The same activity was observed regardless of the order of addition of 
iron and ferroxidase-II. 
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FIGURE 2 
Velocity of the Ferroxidase Reaction as a Function of Substrate 
Concentration 
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Ferroxidase activities were carried out as described in "Experimental 
Methods". The reaction mixture contained 50 µl (0.25 mg) of purified 
ferroxidase-II and varying concentrations of Fe(III). Two entirely separate 
experiments were done and in each experiment multiple determinations were 
done at each substrate concentration. 
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Effect of pH on the Fe(III) Reaction with Ferroxidase-II 
The pH optimum for the Fe(III)-ferroxidase-II reaction was determined 
by measuring the initial rate of oxygen consumption as a function of pH. 
Reaction mixtures were adjusted to specific pH values prior to the 
addition of ferroxidase-II or Fe( III). Since the Fe(III) solutions were 
prepared in 0.1 N HCl, it was necessary to remeasure the pH following the 
injection of Fe(III). Maximum oxygen consumption was observed at a pH of 
. 7. 0 (Figure 3) . 
Determination of Steady-State Kinetic Parameters for the Fe(III)-Initiated 
Reaction 
To determine the ~for Fe(III) for ferroxidase-II, the initial 
rate of oxygen consumption was measured at various Fe( III) concentrations. 
An Eadie-Hofstee plot (v/s vs v) yielded a linear relationship (Figure 4). 
The kinetic parameters calculated from this plot were Km Fe( III) = 10 µM 
and Vmax = 127 µM 02/min/mg p~otein. 
In order to determine the best fitting straight line, a linear re-
gression analysis was performed using the Wang Model 600 programmable 
calculator in conjunction with the x,y plotter. 
The steady-state kinetic parameters obtained for Fe( III) are com-
pared to those previously determined for Fe(II) in Table 1. 
Metal Survey 
Studies were performed to determine whether other metals were capable 
of initiating oxygen consumption in the same manner as Fe(III). 
As seen in Table 2, no other metal ion tested initiated oxygen con-
sumption with ferroxidase-II. 
After each of these ions was added, Fe(III) was introduced into the 
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FIGURE 3 
Effect of pH on the Fe(III) reaction with Ferroxidase-II 
Enzymic assays were performed as described in "Experimental Methods 11 • 
The assay mixture contained 1 x 10-3 M Fe( III), 50 µl (0.909 mg) of pur-
ified ferroxidase-II and 0.2 M acetate buffer pH 3.85 to 7.42 in a final 
volume of 2 ml. The range of the specific activities of several trials 
at each pH is shown but the lines are drawn through the average specific 
activity at each pH. 
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FIGURE 4 
Eadie-Hofstee Plot of the Steady-State Kinetic Data for Fe( III) 
Enzymic assays were performed as described in 11 Experimental Methods 11 • 
Each assay mixture contained 50 µl (0.25 mg) of the purified ferroxidase-II 
solution, 0.2 M acetate buffer, pH 6.0, and concentrations of Fe(III) from 
0.01 mM to 0.3 mM. The best fitting straight line was determined by a 
linear regression analysis performed on the Wang Model 600 programmable 
calculator in conjunction with the x,y plotter. 
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TABLE l 
Comparison of the Kinetic Parameters of Ferroxidase-II 
with Fe(II) and fe(III) 
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Property Fe( III) 
~1 (µM) 14 lO 
Vmax (µM 02/min/mg protein) 102 127 
pH Optimum 7.2 7.0 
1These values reported by Topham and Johnson (35) 
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TABLE 2 
Effect of Metal Ions on Ferroxidase-II Activity 
Cation Specific Ac ti vi ty l, 2 
(1 x io- 3M) (µmoles 02 /min/mg protein) 
Fe( III) 100 
Cu(I I) 0 
Mg(II) 0 
Ni (I I) 0 
Al(III) 0 
Co(II) 0 
Mn( II) 0 
Mo( VI) 0 
1Reaction mixture consists of 0.6 M Acetate buffer (pH 6.0) diluted 
1 to 3, 50 µl (0.409 mg) of purified ferroxidase-II and a final cation 
concentration of 1 x l0-3M. 
2These values represent the specific activity with ferroxidase-II and 
the cation in the absence of Fe(III). Inhibition by Cu(Il) was noted 
when Fe(III) was introduced into the reaction vessel containing 1 x l0-3M 
Cu(II) and ferroxidase-II. 
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reaction vessel to determine the effect, if any, of the various metals 
upon the Fe(III)-initiated reaction. Copper(II) was the only ion found 
to have a significant effect (Figure 5). As indicated, the presence of 
Cu(II) in the reaction mixture resulted in a 55% loss in activity with 
Fe(III). Since copper is an integral part of ferroxidase-II, it may seem 
odd that inhibition is observed with exogenously added copper. However, 
it must be remembered that this is an unusually high level of free copper 
which greatly increases the chances of non-specific binding of copper. 
The copper naturally bound to copper-containing enzymes represents 
only a very small percentage by weight of the enzyme. This copper is 
normally very tightly bound at specific sites in the enzyme structure. 
However, many proteins possess the capability of loosely binding copper, 
particularly if they possess sulfur or nitrogen containing amino acids (1). 
The binding of copper or other heavy metals at these sites frequently 
alters the molecular structure of an enzyme and results in its inactivation. 
Possible Involvement of Fe(III) with an Endogenous Substrate 
The finding that oxygen consumption follo\'1ed injection of Fe(III) 
suggested that iron might serve as an intermediary electron carrier for 
the coupling of electron transfer from an endogenous substrate to fer-
roxidase-II. A possible mechanism for the Fe(III)-coupled reaction is 
as follows: 
Substrate0 x ~2 Fe(!!) 
Substrate d 2 Fe(III) re 
To test whether this mechanism was feasible, it was necessary to show that 
during the course of the reaction ferric iron was reduced to the ferrous state 
FIGURE 5 
Effect of Copper(II) upon the Fe(III)-initiated reaction with 
Ferroxidase-II 
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Enzymic assays were performed as described in 11 Experimental Methods 11 • 
The control assay mixture contained 50 µl (0.909 mg) of purified ferroxidase-
II, 0.2 M acetate buffer, pH 6.0, and an Fe(III) concentration of l x 1Q-3M. 
In the second assay mixture, Cu(II) (l x 10- 3 M final concentration) was 
allowed to incubate with the enzyme prior to the addition of Fe(III). 
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Certain chelating agents, notably a,a'-dipyridyl and l ,10-phenanthro- _ 
line, complex with ferrous iron. These complexes exhibit characteristic 
absorption maximum. The phenanthroline complex has an absorption maximum 
at 510 nm, while the dipyridyl maximum is at 520 nm (39,40). Thus, it 
should be possible to trap the ferrous ion with 1 ,10-phenanthroline or a,a'-
dipyridyl as it is produced in the proposed reaction scheme. This would 
prevent reoxidation of the ferrous ion by ferroxidase-II and little, if any, 
oxygen consumption should be observed. 
When ferroxidase-II was incubated with Fe(III) in the presence of l, 
10-phenanthroline, a distinct absorption maximum at 510 nm appeared. The 
appearance of this peak was indicative of the formation of the Fe(II)-phen-
anthroline complex. The absorption band at 510 nm increased as a function 
of the reaction time (Figure 6). Analogous results were obtained when a,a'-
dipyridyl was substituted for 1, 10-phenanthroline. In this case, the ab-
sorption band appeared at 520 nm, the characteristic Amax for the a,a'-dipyridj 
ferrous complex (Figure 7). Control spectra were run to ascertain that none 
of the reaction components absorbed at either 510 nm or 520 nm (Figure 8) 
Furthermore, no oxygen consumption was observed with reaction mixtures of 
a composition identical to those used for these spectral studies. 
These results strongly support the proposed role of iron as an inter-
mediary electron carrier for the coupling of electron transfer from an en-
dogenous substrate to ferroxidase-II. 
Effect of Fe(III) on the Fe(II) rate with Ferroxidase-II and the Effect of 
Fe(II) on the Fe(III) rate with Ferroxidase-II 
In view of our proposed mechanism, it was felt that it would be in-
teresting to study the effect of pretreatment of ferroxidase-II with Fe(III) 
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FIGURE 6 
Iton Chelating·studies Involving l ,10-Phenanthrolin~ 
The iron-chelating agent spectra were recorded using a Perkin-Elmer 
Model 450 UV-visible NIR spectrophotometer. Spectra were recorded at 
various times after addition of the enzyme. 
Reference cell: reaction mixture(0.2 M Acetate buffer, pH 6.0) 
containing 1 x io- 2 M 1,10-Phenanthroline, 1 x lo-3M Fe(III), 
100 µl of 0.05 M Acetate buffer, pH 5.5 
Sample cell: reaction mixture(0.2 M Acetate buffer, pH 6.0) con-
taining 1 x 10-2 M 1 ,10-Phenanthroline, l x l0-3 M Fe( III), 100 
µl(0.91 mg) ferroxidase-II 
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FIGURE 7 
Iron·chelating Studies Involving a,a'-Dipyridyl 
The iron-chelating agent spectra were recorded using a Perkin-Elmer 
Model 450 UV-visible NIR spectrophotometer. Spectra were recorded at 
various times after addition of the enzyme. 
Reference cell: reaction mixture(0.2 M Acetate buffer, pH 6.0) 
containing 1x10-2 M a,a'-Dipyridyl, 1x10-3 M Fe(III), 100 µl 
of 0.05 M Acetate buffer, pH 5.5 
Sample cell: reaction mixture(0.2 M Acetate buffer, pH 6.0) con-
taining 1 x 10- 2 M a,a' -Dipyridyl, 1 x 10- 3 M Fe( III), 100 µl 
(0.91 mg) ferroxidase-II 
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FIGURE 8 
Control Spectra for Studies Involving Iron Chelating Agents 
These spectra were recorded using a Perkin-Elmer Model 450 UV-visible 
NIR spectrophotometer. 
Curve A 
Reference cell: reaction mixture(0.2 M Acetate buffer, pH 6.0), 
100 µl of 0.05 M Acetate buffer, pH 5.5 
Sample cell: reaction mixture(0.2 M Acetate buffer, pH 6.0), 100 µl 
(0.91 mg) ferroxidase-II 
Curve B 
Reference cell: reaction mixture(0.2 M Acetate buffer, pH 6.0), 
100 µl of 0.05 M Acetate buffer, pH 5.5, 1 x 10-3 M Fe( III) 
Sample cell: reaction mixture(0.2 M Acetate buffer, pH 6.0), 100 µl 
(0.91 mg) ferroxidase-II, l x lo-3M Fe(III) 
Curve C 
Reference cell: reaction mixture(0.2 M Acetate buffer, pH 6.0) 
containing 1 x 10-2 M a,a'-Dipyridyl, 100 µl of 0.05 M Acetate 
buffer, pH 5.5 
Sample cell: reaction mixture(0.2 M Acetate buffer, pH 6.0) con-
taining 1 x 10-2 M a,a'-Dipyridyl, 100 µl(0.91 mg) ferroxidase-II 
Curve D 
Reference cell: reaction mixture(0.2 M Acetate buffer, pH 6.0) 
containing l x 10-2 Ml ,10-Phenanthroline, 100 µl of 0.05 M Acetate 
buffer, pH 5.5 
Sample cell: reaction mixture(0.2 M Acetate buffer, pH 6.0) con-
taining 1 x 10-2 M 1,10-Phenanthroline, 100 µl(0.91 mg) ferroxidase-I: 
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upon the rate of Fe(II} oxidation and the effect of pretreatment of fer-
roxidase-II with Fe(II} upon the Fe(III}-initiated reaction. 
Ferroxidase-II was incubated with various levels of Fe(III) (10 µM to 
250 ~M) for two minutes prior to the introduction of Fe(II) into the reaction 
vessel. The rate of Fe(II) oxidation was decreased at all Fe(III) concen--
trations but with Fe(III) concentrations of 50 µM or greater, there was 
little, if any, oxygen consumption when Fe(II) was added (Figure 9). 
Similar observations were made when the enzyme was preincubated with 
Fe(II) (6 µM to 120 µM) (Figure 10}. With 30 µM Fe(II), the Fe(III) rate 
was reduced by 50% and at those Fe(II) concentrations examined above this, 
there was no measurable Fe(III) rate. 
These findings provide further evidence for the cycling mechanism. 
According to this mechanism, Fe(III) is reduced to Fe(II) which is in turn 
reoxidized to Fe(III). If this is true, then the reaction could be initiated 
by either Fe(II) or Fe(III} and should continue until the endogenous sub-
strate is used up. Thus, if the reac~ion is allowed to go to completion, 
additional Fe(II) or Fe( III) would have no effect. As indicated, these 
findings definitely support the cycling nature of iron. 
Treatment of Ferroxidase-II with OTC 
Previous studies (41) have demonstrated that the electrons removed 
during Fe(II) oxidation by ferroxidase-II are passed to oxygen via the 
copper bound to ferroxidase-II. The mechanism previously illustrated for 
the coupling of Fe(III) with an endogenous substrate would require that 
electrons from the endogenous substrate also be passed to oxygen via the 
copper bound to ferroxidase-II. 
OTC specifically binds Cu(II) and prevents its reduction (42). Almost 
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FIGURE 9 
Effect of Fe(III) on the Fe( II) rate with Ferroxidase-II 
Enzymic assays were performed as described in "Experimental Methods". 
In each assay, 50 µl(0.455 mg) of ferroxidase-II and varying concentrations 
of Fe(III) were allowed to incubate for two minutes prior to the addition 
of 100 µl of 26.4 x l0-4M Fe(II)(l20 µM). Each point represents the aver-
age of three separate experiments. The average specific activity of Fe(II) 
and ferroxidase-II in the absence of Fe(III) was 133 µmoles 02 /min/mg protein. 
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FIGURE 10 
Effect of Fe( II) on the Fe( III) rate with Ferroxidase-II 
Enzymic assays were performed as described in "Experimental Methods". 
In each assay, 50 µl (0.455 mg) of ferroxidase-II and varying concentrations 
of Fe(II) were allowed to incubate for two minutes prior to the addition 
of 0.2 µl of 1 M Fe(III) which yields a final Fe(III) concentration of 
100 µM. The increase in the specific activity resulting from the addition 
of Fe(III) was recorded. The average specific activity of Fe(III) and 
ferroxidase-II in the absence of Fe(II) was 150 µmoles 02/min/mg protein. 
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total loss of Fe(III)-initiated activity was observed with the OTC treated 
enzyme (Table 3). These results suggest that if electrons originate from 
an endogenous substrate via an Fe(III)-coupled reaction they also ultimately 
pass through the ferroxidase-II bound copper in route to oxygen. 
Search for Identity of Endogenous Substrate 
After determining the kinetic parameters of the Fe(III)-initiated 
reaction with ferroxidase-II and obtaining evidence that indicated that 
Fe(III) could serve as an intermediary electron carrier from the endogenous 
substrate to the copper of ferroxidase-II, the next step was to attempt to 
identify the endogenous substrate responsible for this activity. 
Catecholamines as Potential Substrates 
Ferroxidase-lI was purified from blood serum so, it seemed logical 
to examine some components of blood as potential endogenous substrates. 
Walaas et al (43) found that ferroxidase-1 had some oxidase activity 
with the catecholamines: epinephrine, norepinephrine and dopamine .. To 
further differentiate betv1een ferroxi dase- I and II, and in the hope of 
identifying the endogenous substrate with ferroxidase-11, the catecholamines 
were examined to see if they could serve as a substrate for ferroxidase-II. 
In addition to the catecholamines mentioned, serotonin and ascorbic acid 
were also studied as potential substrates. Each compound was made up in 
the reaction mixture to which the ferroxidase-11 and the Fe(lII) were in-
-jected. 
None of the substances tested were found to stimulate the ferroxidase 
activity. Thus, it appeared that none of the catecholamines were capable 
of serving as a substrate for ferroxidase-II. 
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TABLE 3 
Effect of OTC on Oxygen Consumption Initiated by Fe(III)a 
Specific Activity 
{µM 02 /min/rng protein) 
Fe( II) Fe( II I) 
(1.2 x 10-4 M) ( 1 x 10-2 M) 
Control 102.8 83.9 
OTC-Treated 28.4 7.3 
% Inhibition 72.4 91. 3 
aDTC treatments and enzyme assays were performed as described in 
"Experimental Methods 11 
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Treatment of Ferroxidase-11 with Phospholipase C 
Recent work by C.S.M. Sung (32) showed that ferroxidase-II was a 
lipoprotein having cholesterol as well as phospholipids tightly associated 
with it. She observed a very large decrease in the ferroxidase activity 
of samples which had been treated with Phospholipase C. Phospholipases 
are enzymes which catalyze the hydrolysis of phospholipids at the specific 
points illustrated below (44): 
Phospholipase B 
/ H 2CO~C-R1 --111 
Phospholipase A 0 
~ 
· R2-c~LocH 
uT 
0 0 
_LH+ + ?'l- ~CH3)2 
Phospholipase C Phospholipase D 
Phospholipase C hydrolyzes the bond between phosphoric acid and glycerol 
to form a l ,2-diglyceride and a water-soluble phosphorylcholine. 
Sung's (32) observation that ferroxidase activity was lost after 
phospholipase treatment indicated that the lipids were essential for the 
maintenance of enzymic activity. This led to the idea that the endogenous 
substrate for the Fe(III)-initiated ferroxidase reaction might be a lipid 
or at least bound in the lipid matrix of the enzyme. 
To test this hypothesis, three different ferroxidase-II preparations 
were treated with Phospholipase C and examined for loss of Fe(III)-initiated 
activity. As seen in Table 4, hydrolysis with Phospholipase C resulted 
in a dramatic loss of activity with both Fe(II) and Fe(III). To completely 
remove the hydrolyzed lipids, portions of the Phospholipase C treated 
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TABLE 4 
Effect of Phospholipase C treatment on Ferroxidase-II Activity 
Specific Activity 
Treatment ...U1mo l es O~_mi nlm l .nr_ot__ein_l 
l x l0-3 M Fe(III) l. 2 x 10-4 M Fe(I I) 
None 88.5 139.2 
Phospholipase C treatedl 22.3 21.2 
Phospholipase C treated, 
passed over Agarose A-5m1 0 0 
lSimilar losses in activity were observed after each step with all 
three enzyme preparations. 
52 
enzyme were passed over an Agarose A-Sm column (2.5 cm x 27 cm). This 
procedure resulted in a total loss of activity with Fe(II) as well as 
Fe(III). These findings suggest that the endogenous substrate may be a 
lipid or bound in the lipid matrix of the enzyme. 
Examination of Lipid Components of Ferroxidase-II 
The finding that the phospholipase C treatment of ferroxidase-II 
resulted in the loss of activity with the Fe(III)-initiated reaction sug-
gested that the endogenous substrate might be lipid in nature. To further 
investigate this, a purified lipid extract was prepared from ferroxidase-II 
(see experimental), dissolved in various solvents then introduced into 
the reaction vessel with Fe(III) and ferroxidase-II. This was designed to 
determine the extent, if any, of stimulation of the Fe(III)-initiated reac-
tion by the addition of these lipids which had been extracted from ferrox-
i dase-I I. 
Purified Lipids in Normal Reaction Mixture 
The lipid extract was insoluble in the normal reaction mixture(0.6 M 
acetate buffer, pH 6.0) so the solution was homogenized to form a uniform 
suspension. The results of this experiment (TableJ5) indicate that the 
addition of the lipids as a buffer suspension caused no increase in ac-
tivity. 
Although there appeared to be no stimulation, it is possible that 
the lipids were unable to participate in the reaction because they were 
insoluble in the reaction system. Thus, different solvent systems were 
examined. 
Purified Lipids in Triton X-100 
The 1 i pi d extract was ·readily so 1ub1 e in a 10% so 1 uti on of Triton 
TABLE 5 
Examination of Lipid Components of Ferroxidase-II 
as Possible Substratesl,2 
Specific Activity 
(µMoles 02 /min/mg protein) 
Trial 1 Trial 2 Trial 3 Average 
Fe(III), Ferroxidase-II 
0.145 mg lipid extract, Fe(III), Ferroxidase-II 
1.45 mg lipid extract, Fe(III), Ferroxidase-II 
Fe(III), delipidized Ferroxidase-II3 
Fe(III), delipidized Ferroxidase-II3, 
0.145 mg lipid extract 
70.4 67.5 
71.8 67.5 
67.5 
0 
0 
lNormal reaction mixture (0.2 M Acetate buffer, pH 6.0) used as solvent 
2Lipid insoluble, homogenized to form uniform suspension 
3has been through Agarose A-5m 
68.9 
71.8 69.9 
67.5 
0 
0 
01 
w 
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X-100 but there was too much oxygen consumption due to the auto-oxidation 
of the Triton solution. Because of this problem, the Triton system could 
not be used in these studies. 
Purified Lipids in 50% Glycerol 
The lipid extract was suspended in a 50% glycerol solution but there 
was no increase in activity noted. 
Purified Lipids in n-Hexane 
The lipid extract was also found to be soluble in hexane. Additions 
of lipids in a hexane solution caused a slight increase in oxygen consump-
tion but, this was attributed to the hexane rather than the lipids. 
Purified Lipids in Diethyl Ether and Tetrahydrofuran 
Both diethyl ether and tetrahydrofuran were found to be excellent 
solvents for the lipid extract; however, when these solvents were injected 
into the reaction vessel with ferroxidase-II and Fe(III), total inhibition 
of ferroxidase activity was observed. Since tetrahydrofuran and diethyl 
ether inactivated the enzyme, they could not be used in these studies. 
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DISCUSSION 
Ferric iron v!as first examined to determine its inhibitory effect 
upon ferroxidase-II; however, quite surprisingly, an Fe(III)-initiated 
oxidase reaction with ferroxidase-II was observed. Because of this un-
expected finding, a thorough investigation of this Fe(III)-initiated 
reaction was undertaken. 
The finding that saturation kinetics were observed with the Fe(III)-
initiated reaction and that heat treatment resulted in the loss of this 
activity suggested that the oxidase reaction was an enzymic process. 
To explain the Fe(III)-initiated reaction, a mechanism involving iron 
as an intermediary electron carrier for the coupling of electron transfer 
from an endogenous substrate to ferroxidase-II was proposed: 
· substrate0xxFe(II) x Foxox(curl) x H2o 
Substrate ( ) F i 
red Fe III oxred(CuI) /202 
Several pieces of experimental evidence led to the formulation of this 
mechanism and support it as a feasible explanation of the Fe(III)-initiated 
oxidation reaction. 
(1) Spectral studies with Fe(II) chelating agents demonstrate 
that ferric iron is reduced to the ferrous state in the 
presence of ferroxidase-II. 
(2) 
(3) 
The trapping of the ferrous ion by these chelating agents 
would prevent its reoxidation and halt oxygen consumption. 
No oxygen consumption \·1as observed when these ch elating 
agents were included in the reaction mixture at concentra-
tions sufficient to completely trap all of the ferrous 
iron produced. 
This mechanism suggests that Fe(II) and Fe(III) are parti-
cipating at the same site on the enzyme. The kinetic parameters 
of ferroxidase-II with Fe(III) and Fe(II) were found to be 
quite similar. The Km for each was quite low and their maximal 
56 
(3) velocities were nearly equal. The pH optima found with 
Fe(III) and Fe(II) were comparable and the fact that they 
are in the vicinity of neutrality indicates that they 
would be compatible with the pH of blood. 
(4) The mechanism would suggest that the reaction of the en-
dogenous substrate with ferroxidase-II could be initiated 
by either Fe(II) or Fe(III) and this reaction would con-
tinue until oxidation of the endogen9us substrate was 
complete. A two minute preincubation of the enzyme with 
either Fe(II) or Fe(III) was found to considerably reduce 
further oxygen cons ump ti on \I/hen addi ti ona 1 Fe(I I I) or 
Fe(II) was added. 
(5) The mechanism would also imply that the copper associated 
with ferroxidase-II is actively involved in the shuttle 
of electrons from the endogenous substrate to oxygen. The 
potent inhibition of the Fe(III)-initiated oxygen con-
sumption observed with diethyl-dithio-carbamate(DTC), a 
copper specific chelating agent, strongly suggests that 
the copper associated with ferroxidase-II must be involved 
in this reaction. 
(6) The enzymic reaction was initiated specifically by iron 
and substitution by other transition elements resulted 
in no oxygen consur1:ption. Thus, iron must be ideally 
suited to participate in the coupled reaction with the 
endogenous substrate. This indicates that the site on 
the enzyme at which this reaction takes place must have 
some features which make it compatible only with iron. 
Indeed the reduction potent}al of protein-bound iron 
has been found to be more negative than that of protein-
bound copper(45). Thus, it would seem logical for iron 
to be~the initial acceptor of electrons and to pass 
these electrons to copper which in turn would transfer 
the electrons to oxygen. 
Considerable evidence suggested that the proposed mechanism was feasi-
ble. Thus, investigations concerning the isolation and identification of 
the endogenous substrate(or source of endogenous reducing power) were in-
itiated. This presented quite a problem since the substrate appeared to 
be very tightly bound to the enzyme. The substrate remained associated 
with the enzyme through an organic solvent precipitation, an ion exchange 
chromatographic step, ultrafiltration and two gel filtration columns. 
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These purification steps should have removed any impurities or loosely 
bound substances. 
Initially, various oxidizable components of human blood were examined 
in the hopes of finding one which would stimulate the Fe(III)-initiated 
reaction. None of the substances studied caused significant increases in 
activity, so it was decided to approach the problem by an alternative 
method. 
The loss in activity following the hydrolysis of the phospholipids 
associated with ferroxidase-II suggested that the endogenous substrate 
was a lipid or was bound in the lipid matrix of the enzyme. This prompted 
studies with lipid extracts from ferroxidase-II, but numerous problems 
were encountered. 
Attempts to restore the activity of delipidized ferroxidase-II were 
unsuccessful; however, this failure can be explained in several ways. 
Perhaps the most obvious answer is that the phospholipase C treatment 
caused an irreversible alteration in the enzyme's three dimensional struc-
ture thus rendering it inactive. If this were the case, no activity should 
be observed. Difficulties were also encountered in finding a corrmon sol-
vent for the lipid extract and the enzyme. Since the lipids are insoluble 
in an aqueous mixture, it was necessary to find a solvent which would ex-
pose them to the enzyme. Unfortunately, all of the solvents in which the 
enzyme and lipids were mutually soluble were found to inactivate the native 
enzyme. Because of this, our studies were done using suspensions of the 
lipids rather than solutions. This does not assure good interaction be-
tween the enzyme and lipids, so the fact that no activity was observed does 
not conclusively prove that the substrate was not present in the lipid 
extract. 
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Assuming that the phospholipase C treatment might be irreversibly 
altering the enzyme's three dimensional structure, a third approach for 
i denti fyi ng the endogenous substrate \\las attempted. Rather than adding 
the lipid extract to the delipidized ferroxidase-II, it was added to na-
tive ferroxidase-II. This approach suffered from problems similar to 
those encountered with the delipidized enzyme. Here again, a suitable 
solvent for the enzyme and substrate was not found. This lack of a com-
mon solvent turned out to be the major stumbling block in the studies 
with the lipid extracts. 
This is an interesting area which might be explored further, but to 
pursue the theory that the endogenous substrate is a lipid, it would be 
necessary to effect a separation of the individual lipids present in the 
lipid extract. Then, it would be possible to make more concentrated sol-
utions of the individual lipids and examine them to see if they increase 
the activity of the Fe(III)-initiated reaction. 
Even if the lipid responsible for this activity were isolated, it is 
possible that no increase in activity would be observed. It should be 
remembered that in the native enzyme the substrate is already attached to 
the enzyme. It is likely that the enzyme and exogenous lipid would not 
come together in such a manner as to duplicate the binding of the enzyme 
and substrate in the native complex. 
Recently, a quinone-like substance, capable of being oxidized and re-
duced, has been isolated from ferroxidase-II. Although the substance has 
not yet been definitely identified, it appears to be part of the lipid 
matrix and is extremely similar to quinones found in living systems. Based 
upon its chromatographic (column and TLC) behavior, spectral data, and 
chemical tests, the substance is very much like ubiquinone (46). As of 
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this date, sufficient quantities have not been obtained for definitive 
identification or for substrate studies. 
Once sufficient quantities have been isolated, it would be interesting 
to compare its structure before and after treatment with iron. It should 
be possible to determine whether there is an alteration in its structure · 
and whether or not it is being oxidized. 
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